Skip to main content

Peer Review reports

From: Apatinib for patients with advanced or recurrent cervical cancer: study protocol for an open-label randomized controlled trial

Original Submission
11 Feb 2018 Submitted Original manuscript
6 Jun 2018 Reviewed Reviewer Report - David Atallah
13 Jul 2018 Author responded Author comments - Jian-guo Zhou
Resubmission - Version 2
13 Jul 2018 Submitted Manuscript version 2
16 Jul 2018 Reviewed Reviewer Report - David Atallah
27 Jul 2018 Author responded Author comments - Jian-guo Zhou
Resubmission - Version 3
27 Jul 2018 Submitted Manuscript version 3
30 Jul 2018 Author responded Author comments - Jian-guo Zhou
Resubmission - Version 4
30 Jul 2018 Submitted Manuscript version 4
2 Aug 2018 Author responded Author comments - Jian-guo Zhou
Resubmission - Version 5
2 Aug 2018 Submitted Manuscript version 5
12 Aug 2018 Reviewed Reviewer Report - Shelley Potter
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
12 Aug 2018 Editorially accepted
17 Sep 2018 Article published 10.1186/s13063-018-2858-2

You can find further information about peer review here.

Back to article page